XML 28 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Details 1) (USD $)
12 Months Ended
Dec. 31, 2012
Stock Option Activity Merger Agreement
 
Stock options outstanding, beginning of period 0
Stock options granted 823,757
Stock options exercised 0
Stock options forfeited/cancelled 50,102
Stock options outstanding, end of period 773,655
Stock options exercisable, end of period 623,350
Weighted average exercise price granted $ 0.573
Weighted average exercise price outstanding, end of period $ 0.573
Weighted average exercise price exercisable, end of period $ 0.573
Weighted average remaining contractual life outstanding, granted 4 years 8 months
Weighted average remaining contractual life outstanding, end of period 4 years 8 months
Weighted average remaining contractual life exercisable, end of period 4 years 8 months
Stock Option Activity
 
Stock options outstanding, beginning of period 0
Stock options granted 54,519
Stock options outstanding, end of period 54,519
Stock options exercisable, end of period 54,519
Weighted average exercise price granted $ 2.25
Weighted average exercise price outstanding, end of period $ 2.25
Weighted average exercise price exercisable, end of period $ 2.25
Weighted average remaining contractual life outstanding, granted 9 years 9 months
Weighted average remaining contractual life outstanding, end of period 9 years 9 months
Weighted average remaining contractual life exercisable, end of period 9 years 9 months
Stock Option Activity Merger Converted Amount
 
Stock options outstanding, beginning of period 0
Stock options granted 225,000
Stock options outstanding, end of period 225,000
Stock options exercisable, end of period 62,500
Weighted average exercise price granted $ 2.36
Weighted average exercise price outstanding, end of period $ 2.36
Weighted average exercise price exercisable, end of period $ 2.25
Weighted average remaining contractual life outstanding, granted 7 years 1 month
Weighted average remaining contractual life outstanding, end of period 7 years 1 month
Weighted average remaining contractual life exercisable, end of period 4 years 9 months